Interventional Radiological Treatment of Hepatocellular Carcinoma: an Update

Overview

Journal Indian J Surg

Specialty General Surgery

Date 2013 Feb 2

PMID 23372313

Citations 10

Authors

Anurag Shrimal

Madhu Prasanth

A V Kulkarni

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma is the commonest primary liver tumor and its incidence is on an increase.Transplantation and surgical resection are the gold standard curative treatment options but less than 20%patients are surgical candidates because of advanced liver disease and/or co-morbidities.Various interventional radiological procedures have been developed and intensively investigated for treatment of inoperable HCC.This review summarizes the various interventional radiological treatments in HCC including patient selection, procedural considerations and response evaluation. Transarterial chemoembolization, radioembolization and radiofrequency ablation are mainly discussed.

Citing Articles

Interventional nanotheranostics in hepatocellular carcinoma.

Chavda V, Balar P, Patel S Nanotheranostics. 2023; 7(2):128-141.

PMID: 36793354 PMC: 9925354. DOI: 10.7150/ntno.80120.

Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma.

Zhou J, Ling G, Cao J, Ding X, Liao X, Wu M Int J Nanomedicine. 2020; 15:1373-1385.

PMID: 32184592 PMC: 7053813. DOI: 10.2147/IJN.S233989.

Radiofrequency ablation guided by cone beam computed tomography for hepatocellular carcinoma: a comparative study of clinical results with the conventional spiral computed tomography-guided procedure.

Lyu T, Wang J, Cao S, Song L, Tong X, Zou Y J Int Med Res. 2019; 47(8):3699-3708.

PMID: 31248301 PMC: 6726783. DOI: 10.1177/0300060519858010.

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.

Liu C, Li L, Lu W, Du H, Yan L, Wen T BMC Cancer. 2018; 18(1):216.

PMID: 29466970 PMC: 5822668. DOI: 10.1186/s12885-018-4121-3.

Locoregional and systemic therapy for hepatocellular carcinoma.

Gbolahan O, Schacht M, Beckley E, LaRoche T, ONeil B, Pyko M J Gastrointest Oncol. 2017; 8(2):215-228.

PMID: 28480062 PMC: 5401862. DOI: 10.21037/jgo.2017.03.13.

References

Kim Y, Rhim H, Lim H, Choi D, Lee W, Kim S . Hepatic infarction after radiofrequency ablation of hepatocellular carcinoma with an internally cooled electrode. J Vasc Interv Radiol. 2007; 18(9):1126-33. DOI: 10.1016/j.jvir.2007.06.005. View

Ramsey D, Kernagis L, Soulen M, Geschwind J . Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2002; 13(9 Pt 2):S211-21. DOI: 10.1016/s1051-0443(07)61789-8. View

Sasaki Y, Imaoka S, Kasugai H, Fujita M, Kawamoto S, Ishiguro S . A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer. 1987; 60(6):1194-203. DOI: 10.1002/1097-0142(19870915)60:6<1194::aid-cncr2820600607>3.0.co;2-t. View

Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M . Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009; 104(2):514-24. DOI: 10.1038/ajg.2008.80. View

Tamai F, Furuse J, Maru Y, Yoshino M . Intrahepatic pseudoaneurysm: a complication following radio-frequency ablation therapy for hepatocellular carcinoma. Eur J Radiol. 2002; 44(1):40-3. DOI: 10.1016/s0720-048x(01)00436-3. View

Wallace M, Murthy R, Kamat P, Moore T, Rao S, Ensor J . Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol. 2007; 18(12):1500-7. DOI: 10.1016/j.jvir.2007.07.021. View

Olweny C, Toya T, Katongole-Mbidde E, Mugerwa J, Kyalwazi S, Cohen H . Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer. 1975; 36(4):1250-7. DOI: 10.1002/1097-0142(197510)36:4<1250::aid-cncr2820360410>3.0.co;2-x. View

Covey A, Brody L, Maluccio M, Getrajdman G, Brown K . Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology. 2002; 224(2):542-7. DOI: 10.1148/radiol.2242011283. View

Akahane M, Koga H, Kato N, Yamada H, Uozumi K, Tateishi R . Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics. 2005; 25 Suppl 1:S57-68. DOI: 10.1148/rg.25si055505. View

10.

Altekruse S, McGlynn K, Reichman M . Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009; 27(9):1485-91. PMC: 2668555. DOI: 10.1200/JCO.2008.20.7753. View

11.

Lim H, Choi D, Lee W, Kim S, Lee S, Jang H . Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology. 2001; 221(2):447-54. DOI: 10.1148/radiol.2212010446. View

12.

Livraghi T, Solbiati L, Meloni M, Gazelle G, Halpern E, Goldberg S . Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003; 226(2):441-51. DOI: 10.1148/radiol.2262012198. View

13.

Crocetti L, De Baere T, Lencioni R . Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2009; 33(1):11-7. PMC: 2816824. DOI: 10.1007/s00270-009-9736-y. View

14.

Liu D, Salem R, Bui J, Courtney A, Barakat O, Sergie Z . Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005; 16(7):911-35. DOI: 10.1097/01.RVI.0000164324.79242.B2. View

15.

Dodd 3rd G, Soulen M, Kane R, Livraghi T, Lees W, Yamashita Y . Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics. 2000; 20(1):9-27. DOI: 10.1148/radiographics.20.1.g00ja019. View

16.

Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G . Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002; 89(10):1206-22. DOI: 10.1046/j.1365-2168.2002.02168.x. View

17.

Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T . A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005; 129(1):122-30. DOI: 10.1053/j.gastro.2005.04.009. View

18.

Jaskolka J, Asch M, Kachura J, Ho C, Ossip M, Wong F . Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol. 2005; 16(4):485-91. DOI: 10.1097/01.RVI.0000151141.09597.5F. View

19.

Ishii H, Okada S, Nose H, Okusaka T, YOSHIMORI M, Takayama T . Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer. 1996; 77(9):1792-6. DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1792::AID-CNCR6>3.0.CO;2-E. View

20.

Brown D, Geschwind J, Soulen M, Millward S, Sacks D . Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol. 2009; 20(7 Suppl):S317-23. DOI: 10.1016/j.jvir.2009.04.015. View